Emory's comprehensive Advanced Heart Failure and Transplant Cardiology Program has a large patient population, dedicated faculty, and active research that is well integrated with cardiac surgery, electrophysiology, and cardiac imaging. There are more than 5,000 outpatient visits each year and a dedicated inpatient clinical service.
In this program, fellows will receive extensive training in both inpatient and clinical settings, including:
- Hospital management of advanced heart failure
- Pre- and post-transplant evaluation and therapy
- Congenital heart disease evaluation
- Cardiopulmonary exercise testing
- Hemodynamic management of advanced heart failure patients
- CRT/ICD device management
- VAD selection and management
- Outpatient disease management
- End of life care and investigational/research principles
A portion of this fellowship year can be tailored to the career plans of the chosen fellow.
Ongoing research activities include ventricular assist device therapy (VAD), cardiac resynchronization and device diagnostics, disease management, clinical outcomes research, investigational drug therapies, racial disparities in heart failure and allosensitization. Additionally, there is a very active adult congenital heart disease program.
Application Information
We accept one to two fellows per year. Applicants must apply through ERAS for the 2027 interview cycle beginning July 1, 2026. Please refer to ERAS for application submissions.
The prerequisite for this program requires three years of completed (or in progress of being completed) U.S. post graduate training in cardiovascular disease. In addition, at least 3 of the last 6 years of post-graduate training must be in the United States. This is designated as a PGY-7 or higher level position.
Contact Shandala M. Monroe, Fellowship Program Coordinator, with any additional questions.